Metabolism

Incidence of diabetes and obesity are increasing on a global scale and Medpace and our partners are focused on developing new therapies to treat these types of chronic metabolic disorders. Led by an international team of medical and regulatory experts who have helped pioneer many preventative metabolic compounds, Medpace has extensive experience in trial design, drug classes, and disease endpoints for Phase I-IV research. In fact, our years of experience conducting diabetes trials around the world is unmatched by any other Clinical Research Organization (CRO).

Medpace provides comprehensive quality control in the use of dual energy X-ray absorptiometry (DXA) imaging for bone density and body composition in clinical trials. Our experts have helped improve the quality of DXA measurements to the point where regulatory officials now recognize the value of conclusions drawn from these data, potentially streamlining metabolic drug approval.

Leveraging our unique partnering philosophy and established relationships with a global network of investigative sites, our dedicated team members partner with you to target the areas where recruitment will be most effective and deliver strategic and focused execution of every phase of your clinical program.

Former government officials with invaluable insight into the specific area of metabolic drug approval, Medpace experts are involved with every study from program development through marketing applications. Their invaluable guidance guarantees that every phase is correctly focused on advancing your compound closer to regulatory approval.

A commitment to specialized therapeutic categories

Medpace has extensive experience in Phase I-IV research in metabolic disease, with expertise in the following therapeutic categories:

• Diabetes/diabetic nephropathy
• Obesity
• Osteoporosis
• Dyslipidemia

The advantage of metabolic focus

The Medpace family of businesses is strategically organized to support metabolic disease trials by providing a full range of services, including:

• Phase I – IV clinical development, from study start-up through multinational marketing applications
• Medpace Clinical Pharmacology – A state-of-the-art recruitment and diagnostic facility
• Imagepace – Medical imaging core laboratory and centralized reading for pharmaceutical development studies
• Medpace Reference Laboratories – Centralized reference laboratory with specialized testing for metabolic trials
• Medpace Bioanalytical Laboratories – Complete bioanalytical laboratory services deliver accurate, high-quality results

Want to learn more? Contact the Medpace location nearest you.